Study of Tirzepatide for Recovery and Alcohol Use Management
Phase 2
20
about 11 months
18+
2 sites in MA
What this study is about
This trial is testing whether tirzepatide helps people with alcohol use disorder (AUD) manage cravings. Participants will receive either tirzepatide or a placebo weekly for 319 days. The goal is to see if tirzepatide affects how people react to cues related to drinking.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Saline Placebo
- 2.Take Tirzepatide
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
tirzepatide
injection (Injection)
Primary: Incidence and Severity of Adverse Events
Secondary: Blood pressure, Columbia Suicide Severity Rating Scale (C-SSRS), Generalized Anxiety Disorder-7 (GAD-7), Heart rate, Hemoglobin A1c, Patient Health Questionnaire-8 (PHQ-8), Weight
Psychiatry / Mental Health